Understanding parameters
Clinical chemistry influences almost all medical disciplines: most diagnoses are made or confirmed only after the laboratory has determined at least one or two parameters.
Laboratory
Better training could help
Internet-based training for clinicians could help lower antibiotic prescribing rates for acute respiratory tract infections by as much as 62%, according to British researchers.
Carefully selected devices reward MHH with 50% cost cuts
In intensive care units (ICUs) little can be automated to relieve staff pressures – with the exception of point of care testing (POCT)
Diagnostics: Market trends
Nat Whitney, President of Whitney Research, sums up the ups and downs of the international IVD market and reports on a fitting finale for 17 years of dedicated service
An international impact on immunoassay
Snibe, the Shenzhen New Industries Biomedical Engineering Company Ltd., is a leading Chinese biomedical technology company dedicated to developing and manufacturing clinical laboratory equipment and in vitro reagents. Founded 18 years ago and a growing force in the Chinese market, the firm is based in Shenzhen, China’s fourth largest city, situated in Guangdong Province.
New Benchtop Centrifuges from Beckman Coulter
The Allegra X-5 air-cooled benchtop centrifuge from Beckman Coulter Life Sciences is designed specifically for clinical sample preparation.
Heart failure
About 500,000 people in France people suffer heart failure (HF). In Europe the figure is six million and the same in the USA.
Molecular US therapy, computer diagnosis and customized medication
Which technological advancements can we expect to see in the field of medical technology? How well can diagnosis and therapy be customized for each patient?
Raising awareness of in vitro diagnosis values
Labs need to optimise their costs as well as accommodate increasing volumes – and new tests are continuously demanded.
Moving mass spec into the clinical lab
Mass spectrometry has been applied in advanced clinical research and drug discovery and development. Continual innovations have created capabilities to address complex analytical challenges qualitatively and quantitatively with unparalleled speed, sensitivity and accuracy
China looks inward and outward
From the meetings between the Presidents of China and the USA came the slogan, ‘A new model of cooperation’. One item discussed was the proposed $4.6 billion purchase of a US pork producer by a Chinese company, which affirmed: ‘the acquisition won’t affect the quality of the bacon on stateside breakfast tables’.
EuroMedLab 2013
Milan, Italy – The 20th European Congress of Clinical Chemistry and Laboratory Medicine certainly lived up to its claim as the EU’s largest event of its kind – 2,407 visitors and 4,786 delegates from 101 countries plus 82 exhibitors fanned out or arranged themselves over the event’s 3,500 square metres, Hanna Politis reports
Norway leads in POCT quality control
Increasing demand for Point of Care Testing (POCT) devices leads to an increasing number of nurses and physicians working with unfamiliar equipment. Laboratory-quality test results are available in doctor’s surgeries, out-patient clinics and hospital departments. However, how can a high and comparable quality standard for POCT be guaranteed?
LEAN workflow analysis
This year’s EuroMedLab and IFCC-EFLM Congress came at a time when all hospitals face ever-increasing healthcare costs, aging populations and patients and GPs demanding more complex and novel diagnostic tests.
Quality control via round robin tests
If a parameter is determined with different test systems the results must still be comparable. This sounds simple, but is hard to achieve.
Faster sample analysis for UK and EU hospitals
Run by Sheffield Teaching Hospitals NHS Trust, the new automated Medical Laboratory at the Northern General Hospital has drawn a previously fragmented service into a purpose-built centre.
LabsAreVital program out in full force at AACC
The newly relaunched LabsAreVital program will be out in full force at the American Association of Clinical Chemistry (AACC) meeting, from July 28 – August 1 in Houston, Texas.
The American Association for Clinical Chemistry 2013
According to Molly Polen, at the AACC, great opportunities lie ahead for laboratory medicine and, to seize them, ‘meeting with colleagues and learning about new technologies is a critical first step. The 2013 AACC will provide these and other opportunities, such as informative sessions and live demonstrations of new technology.’
Milestone for Hemo Control Haemoglobin Analyser
EKF Diagnostics has recently marked the production at its manufacturing facility in Barleben, Germany, of the 33,333rd Hemo Control, its globally successful haemoglobin point-of-care analyser, since its launch in 2003.
Large-Scale Switch to Digital Pathology Systems
Evolving technologies and market forces reveal that digital pathology is poised to radically affect the daily workflow and activities of pathologists and diagnostic laboratories
Strategic lab control
Managing physicians’ test requests is a key ingredient of modern lab management. However, doctors and nurses still do not provide the clinical reasons for orders to all labs.
Point of care testing
Demand is increasing for point of care (POC) diagnostic testing, particularly for tests that help foster clinical decision-making within 30 minutes or less.
Infectious diseases
Switzerland treads softly when it comes to governing its 26 independent-minded cantons. Yet, when it comes to electronic medical records, the Ministry of Health holds a particular power, not to dare to direct policy inside any canton, but for the exchange of data between the cantons
Snibe makes an entry at EuroMedLab
Snibe, Shenzhen New Industries Biomedical Engineering Co., Ltd., is a leading Chinese biomedical technology company dedicated to developing and manufacturing clinical laboratory equipment and reagents.
Strategic acquisition
Canadian firm Labotix Automation Inc. has been acquired by the Cerner Corporation based in Kansas City, Missouri, USA, amid predictions that the combination of the Labotix’ solution with Cerner Millennium and Cerner Copath will create the most comprehensive set of capabilities on the market to support high volume testing.
